Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one MeSH Supplementary Concept Data 2025


MeSH Supplementary
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one
Unique ID
C074923
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C074923
Entry Term(s)
(+)(-)-FEMEPPEP
(+)-FEMEPPEP
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one, (+)(-)-isomer
FEMEPPEP
Registry Numbers
141117-01-3
141116-96-3
Related Numbers
141116-96-3
Heading Mapped to
*Pyrazoles
*Pyridines
Frequency
1
Note
structure given in first source; more potent than lovastatin in inhibiting cholesterol biosynthesis; RN refers to the (+)-isomer
Source
J Med Chem 1992 May 29;35(11):2095-2103
Date of Entry
1992/07/06
Revision Date
2001/07/17
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one Preferred
(+)-FEMEPPEP Narrower
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one, (+)(-)-isomer Narrower
page delivered in 0.002s